Replies to post #428 on Vascular Biogenics Ltd (VBLT)

[gr8db8]

I do not disagree with you. I think if the drug is fully realized (firstline treatment) then 100 (2.5 bil mkt cap) is low. But many things have to fall in place.

I am cautiously optimistic. More than anything, I want this to work for all the people suffering with GBM. If VB-111 works then it could open up millions in funding for research in this area.